Professor Garry Graham

Book Chapters

Graham GG; Day RO, 2013, 'Salicylates', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Day RO; Graham GG; Williams KM, 2013, 'Propionic acid derivative drugs (Profens)', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Bachmeier CJ; Brooks PM; Day RO; Graham GG; Littlejohn GO; Morand E; Pile K; Williams KM, 2005, 'Disease-modifying anti-rheumatic drugs (DMARD)', in Nijkamp FJ; Parnham MJ (ed.), Principles of Immunopharmacology (2nd Ed), edn. 2nd, Birkhauser Verlag, Basel, pp. 511 - 544

Graham GG, 2005, 'Medicinal chemistry of the disease modifing anti-rheumatic drugs.', in Day RO; Furst DE; van Riel PL; Bresnihan B (ed.), Antirheumatic Therapy: Actions and Outcomes, edn. Original, Birkhauser Verlag, Basel, pp. 1 - 25

Day RO; Quinn DI; March LM; Graham GG; Williams KM, 2000, 'Rheumatoid arthritis. New Frontiers in pathogenesis and treatment', in NSAIDs and analgesics, edn. Original, Oxford University Press, Oxford, England, pp. 307 - 328

Bachmeier CJ; Handel ML; Conaghan PG; Williams KM; Graham GG; Brooks PM; Day RO, 1999, 'Disease-modifying antirheumatic drugs', in Nijkamp FP; Parnham MJ (ed.), Principles of Immunopharmacology, edn. 3, Birkhauser Verlag (Springer), Basel, Switzerland, pp. 379 - 403

Brady S; Day RO; Graham GG, 1999, 'Are Intra-Articular steroids as effective?', in Challenges in Rheumatoid Arthritis, edn. Original, Blackwell Science, Oxford, UK, pp. 174 - 189

Graham GG; Milligan MK; Day RO; Williams KM; Ziegler JB, 1998, 'Therapeutic considerations from pharmacokinetics and metabolism: Ibuprofen and paracetamol', in Rainsford KD; Powanda MC (ed.), SAFETY AND EFFICACY OF NON-PRESCRIPTION (OTC) ANALGESICS AND NSAIDS, SPRINGER, SAN FRANCISCO, CA, pp. 77 - 92, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000081416000006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Conaghan PG; Lehmann T; Brooks P, 1997, 'Disease-modifying antirheumatic drugs', in Current Opinion in Rheumatology, edn. 3, pp. 183 - 190, http://dx.doi.org/10.1097/00002281-199705000-00003

Graham GG; Milligan MK; Day RO; Williams KM; Zeig, 1997, 'Therapeutic considerations from pharmacokinetics and metabolism: ibuprofen and paracetamol', in In: `Safety and efficacy of non-prescription (OTC) analgesics, edn. Original, Kluwer Academic Publishers, Great Britain, pp. 77 - 92

Day RO, 1987, 'Non steroidal anti-inflammatory drugs.', in Australian family physician, edn. 6

Journal articles

Duong JK; Kroonen MYAM; Kumar SS; Heerspink HL; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2017, 'A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function', European Journal of Clinical Pharmacology, vol. 73, pp. 981 - 990, http://dx.doi.org/10.1007/s00228-017-2251-1

Day RO; Kannangara DRW; Stocker SL; Carland JE; Williams KM; Graham GG, 2017, 'Allopurinol: insights from studies of dose–response relationships', Expert Opinion on Drug Metabolism and Toxicology, vol. 13, pp. 449 - 462, http://dx.doi.org/10.1080/17425255.2017.1269745

Kamel B; Graham GG; Williams KM; Pile KD; Day RO, 2017, 'Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat', Clinical Pharmacokinetics, vol. 56, pp. 459 - 475, http://dx.doi.org/10.1007/s40262-016-0466-4

Mahler SM; Wardiana A; Jones ML; de Bakker CJ; Graham GG; Howard CB, 2016, 'Biosimilars approved for treatment of inflammatory rheumatological diseases', International Journal of Rheumatic Diseases, vol. 19, pp. 1043 - 1048, http://dx.doi.org/10.1111/1756-185X.13037

Day RO; Kamel B; Kannangara DRW; Williams KM; Graham GG, 2016, 'Xanthine oxidoreductase and its inhibitors: Relevance for gout', Clinical Science, vol. 130, pp. 2167 - 2180, http://dx.doi.org/10.1042/CS20160010

Smith FC; Kumar SS; Furlong TJ; Gangaram SV; Greenfield JR; Stocker SL; Graham GG; Williams KM; Day RO, 2016, 'Pharmacokinetics of Metformin in Patients Receiving Regular Hemodiafiltration', American Journal of Kidney Diseases, vol. 68, pp. 990 - 992, http://dx.doi.org/10.1053/j.ajkd.2016.08.017

Moon J; Kumar SS; Graham GG; Baysari MT; Williams KM; Chen W; Viardot A; Greenfield JR; Day RO, 2016, 'Trends in metformin utilisation and dose appropriateness in Australia', European Journal of Clinical Pharmacology, vol. 72, pp. 1489 - 1496, http://dx.doi.org/10.1007/s00228-016-2117-y

Kannangara DRW; Phipps-Green AJ; Dalbeth N; Stamp LK; Williams KM; Graham GG; Day RO; Merriman TR, 2016, 'Hyperuricaemia: Contributions of urate transporter ABCG2 and the fractional renal clearance of urate', Annals of the Rheumatic Diseases, vol. 75, pp. 1363 - 1366, http://dx.doi.org/10.1136/annrheumdis-2015-208111

Kannangara DRW; Graham GG; Williams KM; Day RO, 2016, 'Effect of xanthine oxidase inhibitors on the renal clearance of uric acid and creatinine', Clinical Rheumatology, vol. 35, pp. 2375 - 2376, http://dx.doi.org/10.1007/s10067-015-3165-x

Chung WH; Chang WC; Stocker SL; Juo CG; Graham GG; Lee MHH; Williams KM; Tian YC; Juan KC; Wu YJJ, 2015, 'Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: The impact of renal insufficiency, high plasma levels of oxypurinol and granulysin', Annals of the Rheumatic Diseases, vol. 74, pp. 2157 - 2164, http://dx.doi.org/10.1136/annrheumdis-2014-205577

Duong JK; Kumar SS; Furlong TJ; Kirkpatrick CM; Graham GG; Greenfield JR; Williams KM; Day RO, 2015, 'The pharmacokinetics of metformin and concentrations of haemoglobin A1C and lactate in Indigenous and non-Indigenous Australians with type 2 diabetes mellitus', British Journal of Clinical Pharmacology, vol. 79, pp. 617 - 623, http://dx.doi.org/10.1111/bcp.12525

Ghosh D; Williams KM; Graham GG; Nair P; Buscher H; Day RO, 2014, 'Multiple episodes of aspirin overdose in an individual patient: A case report', Journal of Medical Case Reports, vol. 8, http://dx.doi.org/10.1186/1752-1947-8-374

Kannangara DRW; Graham GG; Williams KM; Day RO, 2014, 'Hypouricemic effects of prednisone and allopurinol: An uneven playing field?', Canadian Journal of Cardiology, vol. 30, pp. 376.e1, http://dx.doi.org/10.1016/j.cjca.2013.04.015

Duong JK; Furlong TJ; Roberts DM; Graham GG; Greenfield JR; Williams KM; Day RO, 2013, 'The role of metformin in metformin-associated lactic acidosis (MALA): Case series and formulation of a model of pathogenesis', Drug Safety, vol. 36, pp. 733 - 746, http://dx.doi.org/10.1007/s40264-013-0038-6

Kannangara DRW; Ramasamy SN; Ray JE; Jones G; Graham GG; Williams KM; Day RO, 2013, 'An audit of a therapeutic drug monitoring service for allopurinol therapy', Therapeutic Drug Monitoring, vol. 35, pp. 863 - 866, http://dx.doi.org/10.1097/FTD.0b013e318299920a

Graham GG; Kannangara DRW; Stocker SL; Portek I; Pile KD; Indraratna PL; Datta I; Williams KM; Day RO, 2013, 'Understanding the dose-response relationship of allopurinol: Predicting the optimal dosage', British Journal of Clinical Pharmacology, vol. 76, pp. 932 - 938, http://dx.doi.org/10.1111/bcp.12126

Duong JK; Kumar SS; Kirkpatrick CM; Greenup LC; Arora M; Lee TC; Timmins P; Graham GG; Furlong TJ; Greenfield JR, 2013, 'Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: Simulation of doses according to renal function', Clinical Pharmacokinetics, vol. 52, pp. 373 - 384, http://dx.doi.org/10.1007/s40262-013-0046-9

Day RO; Graham GG, 2013, 'Republished research: Non-steroidal anti-inflammatory drugs (NSAIDs)', British Journal of Sports Medicine, vol. 47, pp. 1127, http://dx.doi.org/10.1136/bjsports-2013-f3195rep

Ramasamy SN; Korb-Wells CS; Kannangara DRW; Smith MWH; Wang N; Roberts DM; Graham GG; Williams KM; Day RO, 2013, 'Allopurinol hypersensitivity: A systematic review of all published cases, 1950-2012', Drug Safety, vol. 36, pp. 953 - 980, http://dx.doi.org/10.1007/s40264-013-0084-0

Day R; Lee H; Graham G; Williams K, 2013, 'Benzbromarone: Availability for general prescribing in New Zealand (a response to letters by Dr Lance Gravatt on benzbromarone)', New Zealand Medical Journal, vol. 126, pp. 124 - 126

Kannangara DRW; Graham GG; Williams KM; Day RO, 2013, 'Hypouricemic Effects of Prednisone and Allopurinol: An Uneven Playing Field?', Canadian Journal of Cardiology, http://dx.doi.org/10.1016/j.cjca.2013.04.015

Brett J; Chong O; Graham GG; Ray JE; Marriott D; Williams KM; Day RO, 2013, 'Antifungal use and therapeutic monitoring of plasma concentrations of itraconazole in heart and lung transplantation patients', Therapeutic Drug Monitoring, vol. 35, pp. 133 - 136, http://dx.doi.org/10.1097/FTD.0b013e318275fe69

Graham GG; Davies MJ; Day RO; Mohamudally A; Scott KF, 2013, 'The modern pharmacology of paracetamol: Therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings', Inflammopharmacology, vol. 21, pp. 201 - 232, http://dx.doi.org/10.1007/s10787-013-0172-x

Day RO; Graham GG, 2013, 'Therapeutics: Non-steroidal anti-inflammatory drugs (NSAIDs)', BMJ (Online), vol. 347, http://dx.doi.org/10.1136/bmj.f3195

Day RO; Graham GG, 2013, 'Non-steroidal anti-inflammatory drugs (NSAIDs).', BMJ (Clinical research ed.), vol. 346, http://dx.doi.org/10.1136/bmj.f3195

Wong C; Kumar SS; Graham GG; Begg EJ; Chin P; Brett J; Ray J; Marriott D; Williams KM; Day RO, 2013, 'Comparing dose prediction software used to manage gentamicin dosing', Internal Medicine Journal, vol. 43, pp. 519 - 525, http://dx.doi.org/10.1111/imj.12067

Stocker SL; Mclachlan AJ; Savic RM; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2012, 'The pharmacokinetics of oxypurinol in people with gout', British Journal of Clinical Pharmacology, vol. 74, pp. 477 - 489, http://dx.doi.org/10.1111/j.1365-2125.2012.04207.x

Kannangara DRW; Roberts DM; Furlong TJ; Graham GG; Williams KM; Day RO, 2012, 'Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease', British Journal of Clinical Pharmacology, vol. 73, pp. 828 - 829, http://dx.doi.org/10.1111/j.1365-2125.2011.04147.x

Kannangara DRW; Ramasamy SN; Indraratna PL; Stocker SL; Graham GG; Jones G; Portek I; Williams KM; Day RO, 2012, 'Fractional clearance of urate: Validation of measurement in spot-urine samples in healthy subjects and gouty patients', Arthritis Research and Therapy, vol. 14, http://dx.doi.org/10.1186/ar4020

Duong JK; Roberts DM; Furlong TJ; Kumar SS; Greenfield JR; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2012, 'Metformin therapy in patients with chronic kidney disease', Diabetes, Obesity and Metabolism, vol. 14, pp. 963 - 965, http://dx.doi.org/10.1111/j.1463-1326.2012.01617.x

Lee MH; Stocker SL; Anderson J; Phillips EJ; Nolan D; Williams KM; Graham GG; Sullivan JR; Day RO, 2012, 'Initiating allopurinol therapy: Do we need to know the patient's human leucocyte antigen status?', Internal Medicine Journal, vol. 42, pp. 411 - 416, http://dx.doi.org/10.1111/j.1445-5994.2011.02567.x

Kannangara D; Datta I; Indraratna P; Stocker S; Portek I; Graham G; Williams K; Day R, 2011, 'INDIVIDUALISING ALLOPURINOL THERAPY IN GOUT', INTERNAL MEDICINE JOURNAL, vol. 41, pp. 30 - 30, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Ramasamy S; Kannangara D; Indraratna P; Stocker S; Jones G; Graham G; Williams K; Day R, 2011, 'ESTABLISHING THE USEFULNESS OF A SPOT URINE COLLECTION IN CALCULATING THE FRACTIONAL RENAL CLEARANCE OF URATE (FCU)', INTERNAL MEDICINE JOURNAL, vol. 41, pp. 31 - 31, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Bryant KJ; Bidgood MJ; Lei PW; Taberner M; Salom C; Kumar V; Lee L; Church WB; Courtenay B; Smart BP, 2011, 'A bifunctional role for group IIA secreted phospholipase A2 in human rheumatoid fibroblast-like synoviocyte arachidonic acid metabolism', Journal of Biological Chemistry, vol. 286, pp. 2492 - 2502, http://dx.doi.org/10.1074/jbc.M110.123927

Ng DY; Stocker SL; Graham GG; Williams KM; Day RO, 2011, 'Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers', European Journal of Clinical Pharmacology, vol. 67, pp. 709 - 713, http://dx.doi.org/10.1007/s00228-010-0963-6

Graham GG; Punt J; Arora M; Day RO; Doogue MP; Duong JK; Furlong TJ; Greenfield JR; Greenup LC; Kirkpatrick CM, 2011, 'Clinical pharmacokinetics of metformin', Clinical Pharmacokinetics, vol. 50, pp. 81 - 98, http://dx.doi.org/10.2165/11534750-000000000-00000

Greenfield JR; Graham GG; Day RO, 2011, 'The Use of Metformin in Diabetic Patients with Renal Impairment', Geriatric Medicine in General Practice, vol. 8, pp. 26 - 29, http://search.informit.com.au/documentSummary;dn=109054076198131;res=IELHEA

Ray J; Campbell G; Richardson T; Erickson G; Carr V; Rofe P; Tassaneeyakul W; Graham G, 2010, 'OPTIMISING CLOZAPINE THERAPY: A NEW MODEL OF CLOZAPINE THERAPEUTIC DRUG MONITORING', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, vol. 44, pp. A26 - A26, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282954700069&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Koelsch M; Mallak R; Graham GG; Kajer T; Milligan MK; Nguyen LQ; Newsham DW; Keh JS; Kettle AJ; Scott KF, 2010, 'Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations', Biochemical Pharmacology, vol. 79, pp. 1156 - 1164, http://dx.doi.org/10.1016/j.bcp.2009.11.024

Graham GG; Day RO; Graudins A; Mohamudally A, 2010, 'Erratum: FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): Are they reasonable? (Inflammopharmacol DOI: 10.1007/s10787-010-0036-6)', Inflammopharmacology, vol. 18, pp. 57, http://dx.doi.org/10.1007/s10787-010-0039-3

Indraratna PL; Williams KM; Graham GG; Day RO, 2009, 'Hyperuricemia, cardiovascular disease, and the metabolic syndrome', Journal of Rheumatology, vol. 36, pp. 2842 - 2843, http://dx.doi.org/10.3899/jrheum.090500

McLachlan A; Day R; Williams K; Graham G; Stocker S, 2008, 'Maximising gout therapy', Australian Journal of Pharmacy, vol. 89, pp. 86 - 88

Nevalainen TJ; Graham GG; Scott KF, 2008, 'Antibacterial actions of secreted phospholipases A2. Review', Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, vol. 1781, pp. 1 - 9, http://dx.doi.org/10.1016/j.bbalip.2007.12.001

Stocker SL; Williams KM; McLachlan AJ; Graham GG; Day RO, 2008, 'Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects', Clinical Pharmacokinetics, vol. 47, pp. 111 - 118, http://dx.doi.org/10.2165/00003088-200847020-00004

Chung Y; Stocker SL; Graham GG; Day RO, 2008, 'Optimizing therapy with allopurinol: Factors limiting hypouricemic efficacy', American Journal of the Medical Sciences, vol. 335, pp. 219 - 226, http://dx.doi.org/10.1097/MAJ.0b013e31815acb10

Chung Y; Lu CY; Graham GG; Mant A; Day RO, 2008, 'Utilization of allopurinol in the Australian community', Internal Medicine Journal, vol. 38, pp. 388 - 395, http://dx.doi.org/10.1111/j.1445-5994.2008.01641.x

Graham GG; Whitehouse MW; Bushell GR, 2008, 'Aurocyanide, dicyano-aurate (I), a pharmacologically active metabolite of medicinal gold complexes', Inflammopharmacology, vol. 16, pp. 126 - 132, http://dx.doi.org/10.1007/s10787-007-0020-y

Lee MHH; Graham GG; Williams KM; Day RO, 2008, 'A benefit-risk assessment of benzbromarone in the treatment of gout: Was its withdrawal from the market in the best interest of patients?', Drug Safety, vol. 31, pp. 643 - 665, http://dx.doi.org/10.2165/00002018-200831080-00002

Day RO; Graham G; Williams K, 2007, 'Fenofibratewarfarin interaction [1]', Australian Prescriber, vol. 30, pp. 32

Graham GG; Day RO, 2007, 'Expert comment [6]', Australian Prescriber, vol. 30, pp. 61 - 62

Day RO; Graham GG; Hicks M; McLachlan AJ; Stocker SL; Williams KM, 2007, 'Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol', Clinical Pharmacokinetics, vol. 46, pp. 623 - 644, http://dx.doi.org/10.2165/00003088-200746080-00001

Dong Q; Patel M; Scott KF; Graham GG; Russell PJ; Sved P, 2006, 'Oncogenic action of phospholipase A2 in prostate cancer', Cancer Letters, vol. 240, pp. 9 - 16, http://dx.doi.org/10.1016/j.canlet.2005.08.012

Byrne A; Graham G; Hallinan R; Murnion B; Hulse GK; Arnold-Reed DE; Wodak A; Graham R; Hulse GK, 2005, 'Naltrexone implants as treatment for heroin dependence: Part I (multiple letters)', Addiction Biology, vol. 10, pp. 201 - 204, http://dx.doi.org/10.1080/13556210500155789

Scott KF; Lei P-W; Lee LK; Bidgood MJ; Taberner M; Salom C; Courtenay BG; Bryant KJ; Church WB; Graham GG, 2005, 'Regulation of intracellular prostaglandin biosynthetic pathways by "outside-in" secreted phospholipase A(2)-dependent signalling in fibroblast-like synoviocytes', INFLAMMATION RESEARCH, vol. 54, pp. S182 - S182, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000205501600313&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Graham GG; Scott KF, 2005, 'Mechanism of action of paracetamol', American Journal of Therapeutics, vol. 12, pp. 46 - 55, http://dx.doi.org/10.1097/00045391-200501000-00008

Day RO; Graham GG, 2005, 'Paracetamol should be first-line therapy in osteoarthritis [4]', Medical Journal of Australia, vol. 182, pp. 198 - 199

Graham GG; Scott KF; Day RO, 2005, 'Tolerability of paracetamol', Drug Safety, vol. 28, pp. 227 - 240, http://dx.doi.org/10.2165/00002018-200528030-00004

Lee EJD; Williams K; Day R; Graham G; Champion D; Geisslinger G, 2004, 'Stereoselective disposition of ibuprofen enantiomers in man', British Journal of Clinical Pharmacology, vol. 58

Sved P; Scott KF; McLeod D; King NJC; Singh J; Tsatralis T; Nikolov B; Boulas J; Nallan L; Gelb MH, 2004, 'Oncogenic action of secreted phospholipase A2 in prostate cancer', Cancer Research, vol. 64, pp. 6934 - 6940, http://dx.doi.org/10.1158/0008-5472.CAN-03-3018

Day RO; Graham GG, 2004, 'The vascular effects of COX-2 selective inhibitors', Australian Prescriber, vol. 27, pp. 142 - 145, http://dx.doi.org/10.18773/austprescr.2004.119

Graham GG; Scott KF; Day RO, 2003, '[Tolerability of paracetamol].', Drugs, vol. 63 Spec No 2, pp. 43 - 46, https://www.ncbi.nlm.nih.gov/pubmed/14758789

Graham GG; Scott KF; Day RO, 2003, 'Tolerability of Paracetamol', Drugs, vol. 63, pp. 43 - 46, http://dx.doi.org/10.2165/00003495-200363992-00007

Scott KF; Graham GG; Bryant KJ, 2003, 'Secreted phospholipase A2 enzymes as therapeutic targets', Expert Opinion on Therapeutic Targets, vol. 7, pp. 427 - 440, http://dx.doi.org/10.1517/14728222.7.3.427

Graham GG; Scott KF, 2003, 'Mechanisms of action of paracetamol and related analgesics', Inflammopharmacology, vol. 11, pp. 401 - 413, http://dx.doi.org/10.1163/156856003322699573

Scott KF; Graham GG; Bryant KJ, 2003, 'Secreted phospholipase A2 enzymes as therapeutic targets', Expert Opinion on Therapeutic Targets, vol. 7, pp. 427 - 440

Graham GG; Kettle AJ, 2002, 'Formation of aurocyanide by lactoperoxidase and its inhibition by paracetamol (acetaminophen)', FREE RADICAL BIOLOGY AND MEDICINE, vol. 33, pp. S178 - S178, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000177096300470&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Graham GG; Graham RI; Day RO, 2002, 'Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol)', Current Pharmaceutical Design, vol. 8, pp. 1063 - 1075, http://dx.doi.org/10.2174/1381612023394917

Graham GG; Robins SA; Bryant KJ; Scott KF, 2001, 'Inhibition of prostaglandin synthesis in intact cells by paracetamol (acetaminophen)', Inflammopharmacology, vol. 9, pp. 131 - 142, http://dx.doi.org/10.1163/156856001300248407

Day RO; Graham GG; Whelton A, 2000, 'The position of paracetamol in the world of analgesics', American Journal of Therapeutics, vol. 7, pp. 51 - 54, http://dx.doi.org/10.1097/00045391-200007020-00002

Morlet N; Graham GG; Gatus B; Mclachlan AJ; Salonikas C; Naidoo D; Goldberg I; Lam CM, 2000, 'Pharmacokinetics of ciprofloxacin in the human eye: A clinical study and population pharmacokinetic analysis', Antimicrobial Agents and Chemotherapy, vol. 44, pp. 1674 - 1679, http://dx.doi.org/10.1128/AAC.44.6.1674-1679.2000

Day RO; Graham GG; Whelton A, 2000, 'The position of paracetamol in the world of analgesics.', American Journal of Therapeutics, pp. 51 - 54

Morlet N; Graham GG; Gatus BJ; Mclachlan AJ; Salonikas C; Naidoo D; Goldberg I; Lam CK, 2000, 'The pharmacokinetics of ciprofloxacin in the human eye: A clinical study and population pharmacokinetic analysis', Antimicrobial Agents and Chemotherapy, pp. 1674 - 1679

Begg EJ; Robson RA; Saunders DA; Graham GG; Buttimore RC; Neill AM; Town GI, 2000, 'The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing', British Journal of Clinical Pharmacology, pp. 32 - 38

Graham GG; Day RO; Milligan MK; Ziegler JB; Kettle AJ, 1999, 'Current concepts of the actions of paracetamol (acetaminophen) and NSAIDS', Inflammopharmacology, vol. 7, pp. 255 - 263, http://dx.doi.org/10.1007/s10787-999-0008-x

Day RO; McLachlan AJ; Graham GG; Williams KM, 1999, 'Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid', Clinical Pharmacokinetics, vol. 36, pp. 191 - 210, http://dx.doi.org/10.2165/00003088-199936030-00002

Quane PA; Graham GG; Ziegler JB, 1998, 'Pharmacology of benzydamine', Inflammopharmacology, vol. 6, pp. 95 - 107, http://dx.doi.org/10.1007/s10787-998-0026-0

Warwick NR; Graham GG; Torda TA, 1998, 'Pharmacokinetic analysis of the effect of vecuronium in surgical patients - Pharmacokinetic and pharmacodynamic modeling without plasma concentrations', ANESTHESIOLOGY, vol. 88, pp. 874 - 884, http://dx.doi.org/10.1097/00000542-199804000-00005

Graham GG; Kettle AJ, 1998, 'The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes - III. The formation of aurocyanide by myeloperoxidase', BIOCHEMICAL PHARMACOLOGY, vol. 56, pp. 307 - 312, http://dx.doi.org/10.1016/S0006-2952(98)00031-8

Graham GG; Kettle AJ, 1998, 'The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes. III. The formation of aurocyanide by myeloperoxidase.', Biochem Pharmacol, vol. 56, pp. 307 - 312, http://dx.doi.org/10.1016/s0006-2952(98)00031-8

Warwick NR; Graham CG; Torda TA, 1998, 'Pharmacokinetic analysis of the effect of vecuronium in surgical patients: Pharmacokinetic and pharmacodynamic modeling without plasma concentrations', Anesthesiology, vol. 88, pp. 874 - 884, http://dx.doi.org/10.1097/00000542-199804000-00005

Bolisetty S; Gupta JM; Graham GG; Salonikas C; Naidoo D, 1998, 'Vitamin K in preterm breastmilk with maternal supplementation', Acta Paediatrica, International Journal of Paediatrics, vol. 87, pp. 960 - 962, http://dx.doi.org/10.1080/080352598750031626

Bollisetty S; Gupta JM; Graham GG; Salonikas C; Naidoo D, 1998, 'Vitamin K in preterm breastmilk with maternal supplementation', ACTA Paediatrica, pp. 960 - 962

Torda TA; Graham GG; Warwick NR; Donohue P, 1997, 'Pharmacokinetics and pharmacodynamics of suxamethonium', Anaesthesia and Intensive Care, vol. 25, pp. 272 - 278

Torda TA; Graham GG; Warwick NR, 1997, 'A normal distribution model for the pharmacodynamics of nondepolarizing neuromuscular blockers', Anaesthesia and Intensive Care, vol. 25, pp. 279 - 281

Saunders DA; Begg EJ; Kirkpatrick CMJ; Yeo J; Graham GG; Bailey RR, 1997, 'Measurement of total phospholipids in urine of patients treated with gentamicin', British Journal of Clinical Pharmacology, vol. 43, pp. 435 - 440, http://dx.doi.org/10.1046/j.1365-2125.1997.00568.x

Torda TA; Graham GG; Warwick NR; Donohue PM, 1997, 'Pharmacokinetics and pharmacodynamics of suxamethonium', Anaesthesia and Intensive Care, pp. 272 - 278

Torda TA; Graham GG; Warwick NR, 1997, 'A normal distribution model fo r the pharmacodynamics of nondepolarising neuromuscular blockers', Anaesthesia and Intensive Care, pp. 279 - 281

Graham GG; Gordon D; Sadler PJ, 1996, 'Reactions of the Antiarthritic Drug Aurothiomalate With Phenylmercury(II) Compounds: NMR Studies.', Met Based Drugs, vol. 3, pp. 269 - 276, http://dx.doi.org/10.1155/MBD.1996.269

Whitehouse MW; Graham GG, 1996, 'Is local biotransformation the key to understanding the pharmacological activity of salicylates and gold drugs?', Inflammation Research, vol. 45, pp. 579 - 582, http://dx.doi.org/10.1007/BF02312038

Morlet N; Young S; Naidoo D; Graham G; Coroneo MT, 1996, 'High dose intravitreal ganciclovir injection provides a prolonged therapeutic intraocular concentration', British Journal of Ophthalmology, vol. 80, pp. 214 - 216, http://dx.doi.org/10.1136/bjo.80.3.214

Graham S; Day RO; Wong H; Mclachlan AJ; Bergendal L; Miners JO; Birkett DJ, 1996, 'Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects', British Journal of Clinical Pharmacology, vol. 41, pp. 299 - 304

Morlet N; Young S; Naidoo D; Graham GG; Coroneo MT, 1996, 'High dose intravitreal gonciclovir injection provides a prolonged therapeutic intracular concentration', British Journal of Ophthalmology, pp. 214 - 216

YOUNG SH; MORLET N; GRAHAM G; NAIDOO D; CORONEO MT, 1995, 'IMPROVED TREATMENT OF CMV RETINITIS USING HIGH-DOSE INTRAVITREAL GANCICLOVIR WITH PROLONGED THERAPEUTIC INTRAOCULAR CONCENTRATIONS', INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 36, pp. S323 - S323, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995QM91501503&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

MORLET N; STAYT J; NAIDOO D; GRAHAM G; CROUCH R; CORONEO MT, 1995, 'VIROCIDAL TREATMENT OF CMV RETINITIS', INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 36, pp. S181 - S181, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995QM91500858&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Warwick NR; Graham GG; Torda TA, 1995, 'Pharmacokinetic analysis of the time course of effect of atracurium', Clinical Pharmacology and Therapeutics, vol. 57, pp. 390 - 397, http://dx.doi.org/10.1016/0009-9236(95)90207-4

Warwick NR; Graham GG; Torda TA, 1995, 'Pharmacokinetic analysis of the time course of effect of atracurium', Clinical Pharmacology and Therapeutics, pp. 390 - 397

MISHRA Y; TORDA T; RAMZAN I; GRAHAM G, 1994, 'In‐vitro Interaction between H2 Antagonists and Vecuronium', Journal of Pharmacy and Pharmacology, vol. 46, pp. 205 - 208, http://dx.doi.org/10.1111/j.2042-7158.1994.tb03779.x

LAU ATS; GRAHAM GG; DAY RO; PERRY MA, 1994, 'EFFECT OF HCL CONCENTRATION ON GASTRIC BLOOD-FLOW IN ACUTE ASPIRIN-INDUCED GASTRIC-ULCERS IN THE CAT', GASTROENTEROLOGY, vol. 106, pp. A123 - A123, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994NH90900484&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Graham GG; Champion GD; Ziegler JB, 1994, 'The cellular metabolism and effects of gold complexes.', Met Based Drugs, vol. 1, pp. 395 - 404, http://dx.doi.org/10.1155/MBD.1994.395

Seideman P; Lohrer F; Graham G; Duncan M; Williams K; Day R, 1994, 'The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid.', British Journal of Clinical Pharmacology, vol. 38, pp. 221 - 227, http://dx.doi.org/10.1111/j.1365-2125.1994.tb04345.x

Day RO; Birkett DJ; Hicks M; Miners JO; Graham GG; Brooks PM, 1994, 'New Uses for Allopurinol', Drugs, vol. 48, pp. 339 - 344, http://dx.doi.org/10.2165/00003495-199448030-00002

Palasanthiran P; Robertson P; Ziegler JB; Graham GG, 1994, 'Decay of transplacental human immunodeficiency virus type 1 antibodies in neonates and infants', Journal of Infectious Diseases, vol. 170, pp. 1593 - 1596, http://dx.doi.org/10.1093/infdis/170.6.1593

Torda TA, 1994, 'The Kinetics of Effect of Neuromuscular Blocking Drugs', The Keio Journal of Medicine, vol. 43, pp. 27 - 30, http://dx.doi.org/10.2302/kjm.43.27

Brooks PM; Day RO; Graham GG; Williams KM, 1993, 'Preface', Agents and Actions, vol. 44

TORDA TA; GRAHAM GG; WARWICK NR, 1993, 'GAUSSIAN MODEL OF THE PHARMACODYNAMICS OF THE NEUROMUSCULAR-JUNCTION', ANESTHESIOLOGY, vol. 79, pp. A922 - A922, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993LY10800921&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Meyer-Carrive I; Graham GG; Ghosh P, 1993, 'Pharmacokinetics of tiaprofenic acid in normal rabbits and rabbits subjected to joint immobilisation', Agents and Actions, vol. 39, pp. 59 - 68, http://dx.doi.org/10.1007/BF01975715

Day RO; Brooks PM; Williams KM; Graham GG, 1993, 'Third World conference on variability in response to anti-rheumatic drugs, Singapore, July 22-24, 1992.', Agents and actions, vol. 38

Davis AL; Begg EJ; Kennedy MC; Graham GG, 1993, 'Application of a simplified method to determine bioavailability of an oral dose of phenytoin', Journal of Pharmacokinetics and Biopharmaceutics, vol. 21, pp. 195 - 208, http://dx.doi.org/10.1007/BF01059770

Day RO; Brooks PM; Williams KM; Graham GG, 1993, 'Meeting report: Third world conference on variability in response to anti-rheumatic drugs, Singapore, July 22-24, 1992', Agents and Actions, vol. 38

Lau ATS; Graham GG; Day RO; Perry MA, 1992, 'Effect of aspirin on ulcer site blood flow in cat stomachs', American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 263

Rudkowski R; Ziegler JB; Graham GG; Joulianos G, 1992, 'Gold complexes and activation of human polymorphonuclear leukocytes. Dissociation of changes in membrane potential and oxidative burst', Biochemical Pharmacology, vol. 44, pp. 1091 - 1098, http://dx.doi.org/10.1016/0006-2952(92)90372-P

LAU ATS; GRAHAM GG; DAY RO; PERRY MA, 1992, 'EFFECT OF ASPIRIN ON ULCER SITE BLOOD-FLOW IN CAT STOMACHS', AMERICAN JOURNAL OF PHYSIOLOGY, vol. 263, pp. G155 - G160, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992JJ95800072&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Lau AT; Graham GG; Day RO; Perry MA, 1992, 'Effect of aspirin on ulcer site blood flow in cat stomachs.', Am J Physiol, vol. 263, pp. G155 - G160, http://dx.doi.org/10.1152/ajpgi.1992.263.2.G155

Graham GG; Champion GD; Ziegler JB, 1991, 'The antirheumatic gold complexes: Considerations of chemical form in studies on their mechanism of action', Inflammopharmacology, vol. 1, pp. 99 - 102, http://dx.doi.org/10.1007/BF02735391

Rudkowski R; Graham GG; Ziegler JB; Champion GD, 1991, 'The effect of aurothiomalate on the oxidative burst of polymorphonuclear leukocytes varies with the quantity of drug in myocrisin ampoules', Journal of Rheumatology, vol. 18, pp. 666 - 671

Rudkowski R; Ziegler JB; Graham GG; Champion GD, 1991, 'Auranofin inhibits the activation pathways of polymorphonuclear leukocytes at multiple sites', Biochemical Pharmacology, vol. 41, pp. 1921 - 1929, http://dx.doi.org/10.1016/0006-2952(91)90132-O

Carmody JJ; Graham GG; Ruigrok MA, 1991, 'STRESS IN MICE INCREASES INTRINSIC PENTOBARBITONE SENSITIVITY BY A PREDOMINANTLY PHARMACODYNAMIC MECHANISM', Clinical and Experimental Pharmacology and Physiology, vol. 18, pp. 703 - 710, http://dx.doi.org/10.1111/j.1440-1681.1991.tb01384.x

Graham GG; Dale MM, 1990, 'The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes-II. Evidence for the formation and biological activity of aurocyanide', Biochemical Pharmacology, vol. 39, pp. 1697 - 1702, http://dx.doi.org/10.1016/0006-2952(90)90113-Y

Rudkowski R; Graham GG; Champion GD; Ziegler JB, 1990, 'The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes-I. The effects of aurocyanide on the oxidative burst of polymorphonuclear leukocytes', Biochemical Pharmacology, vol. 39, pp. 1687 - 1695, http://dx.doi.org/10.1016/0006-2952(90)90112-X

Champion GD; Graham GG; Ziegler JB, 1990, 'The gold complexes', Bailliere's Clinical Rheumatology, vol. 4, pp. 491 - 534, http://dx.doi.org/10.1016/S0950-3579(05)80005-6

Knihinicki RD; Day RO; Graham GG; Williams KM, 1990, 'Stereoselective disposition of ibuprofen and flurbiprofen in rats', Chirality, vol. 2, pp. 134 - 140, http://dx.doi.org/10.1002/chir.530020303

Torda TA; Graham GG; Tsui D, 1990, 'Neuromuscular sensitivity to atracurium in humans', Anaesthesia and Intensive Care, vol. 18, pp. 62 - 68

Graham GG; Tsui D; Torda TA, 1990, 'A simplified approach to the effect kinetics of atracurium', British Journal of Anaesthesia, vol. 64, pp. 28 - 32, http://dx.doi.org/10.1093/bja/64.1.28

Graham GG; Torda TA; Tsui D, 1990, 'A simplified analysis of the kinetics of effect of muscle relaxants', European Journal of Pharmacology, vol. 183, pp. 1594 - 1595, http://dx.doi.org/10.1016/0014-2999(90)94760-U

Day R; Graham G; Bieri D; Brown M; Cairns D; Harris G; Hounsell J; Platt‐ Hepworth S; Reeve R; Sambrook P, 1989, 'Concentration‐response relationships for salicylate‐induced ototoxicity in normal volunteers.', British Journal of Clinical Pharmacology, vol. 28, pp. 695 - 702, http://dx.doi.org/10.1111/j.1365-2125.1989.tb03562.x

Rauch K; Ray J; Graham G, 1988, 'Improved high-performance liquid chromatographic method for the determination of quinine in plasma', Journal of Chromatography B: Biomedical Sciences and Applications, vol. 430, pp. 170 - 174, http://dx.doi.org/10.1016/S0378-4347(00)83148-5

Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; De Jager J, 1988, 'Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis', Journal of Rheumatology, vol. 15, pp. 28 - 34

RUDKOWSKI R; JACOB M; GRAHAM GG; CHAMPION GD, 1988, 'IS AUROTHIOMALATE AN ACTIVATOR OR INHIBITOR OF HUMAN-NEUTROPHILS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, vol. 18, pp. 521 - 521, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988N917000676&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Day R; Harris G; Brown M; Graham G; Champion G, 1988, 'Interaction of salicylate and corticosteroids in man.', British Journal of Clinical Pharmacology, vol. 26, pp. 334 - 337, http://dx.doi.org/10.1111/j.1365-2125.1988.tb05286.x

Day R; Miners J; Birkett D; Graham G; Whitehead A, 1988, 'Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.', British Journal of Clinical Pharmacology, vol. 26, pp. 429 - 434, http://dx.doi.org/10.1111/j.1365-2125.1988.tb03402.x

Day RO; Williams KM; Graham GG; Lee EJ; Knihinicki RD; Champion GD, 1988, 'Stereoselective disposition of ibuprofen enantiomers in synovial fluid', Clinical Pharmacology and Therapeutics, vol. 43, pp. 480 - 487, http://dx.doi.org/10.1038/clpt.1988.62

Day RO; Graham GG; Willia KM; Brooks PM, 1988, 'Variability in Response to NSAIDs: Fact or Fiction?', Drugs, vol. 36, pp. 643 - 651, http://dx.doi.org/10.2165/00003495-198836060-00001

Graham GG, 1988, 'Kinetics of non-steroidal anti-inflammatory drugs in synovial fluid.', Agents and actions. Supplements, vol. 24, pp. 66 - 75

Day RO; Graham GG; Williams KM, 1988, 'Pharmacokinetics of non-steroidal anti-inflammatory drugs', Bailliere's Clinical Rheumatology, vol. 2, pp. 363 - 393, http://dx.doi.org/10.1016/S0950-3579(88)80019-0

RUDKOWSKI R; CHAMPION GD; GRAHAM GG; ZIEGLER JB, 1987, 'THE EFFECTS OF AUROCYANIDE, AUROTHIOMALATE AND AURANOFIN ON THE OXIDATIVE BURST OF POLYMORPHONUCLEAR LEUKOCYTES', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, vol. 17, pp. 117 - 117, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1987G353300027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Day RO; Graham GG; Williams KM; David Champion G; de Jager J, 1987, 'Clinical pharmacology of non-steroidal anti-inflammatory drugs', Pharmacology and Therapeutics, vol. 33, pp. 383 - 433, http://dx.doi.org/10.1016/0163-7258(87)90072-6

Bochner F; Graham GG; Polverino A; Imhoff DM; Tregenza RA; Rolan PE; Cleland LG, 1987, 'Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis', European Journal of Clinical Pharmacology, vol. 32, pp. 153 - 158, http://dx.doi.org/10.1007/BF00542188

Tsui D; Graham GG; Torda TA, 1987, 'The pharmacokinetics of atracurium isomers in vitro and in humans.', Anesthesiology, vol. 67, pp. 722 - 728, http://dx.doi.org/10.1097/00000542-198711000-00017

Graham GG, 1987, 'Pharmacokinetics and metabolism of non-steroidal anti-inflammatory drugs', Medical Journal of Australia, vol. 147, pp. 597 - 602

Graham GG; Morris R; Pybus DA; Torda TA; Woodey R, 1986, 'Relationship of train-of-four ratio to twitch depression during pancuronium-induced neuromuscular blockade', Anesthesiology, vol. 65, pp. 579 - 583, http://dx.doi.org/10.1097/00000542-198612000-00003

Lee E; Williams K; Day R; Graham G; Champion D, 1985, 'Stereoselective disposition of ibuprofen enantiomers in man.', British Journal of Clinical Pharmacology, vol. 19, pp. 669 - 674, http://dx.doi.org/10.1111/j.1365-2125.1985.tb02694.x

Graham GG; Bales JR; Grootveld MC; Sadler PJ, 1985, '1H, 13C NMR, and electronic absorption spectroscopic studies of the interaction of cyanide with aurothiomalate.', J Inorg Biochem, vol. 25, pp. 163 - 173, https://www.ncbi.nlm.nih.gov/pubmed/3934340

Graham GG; Bales JR; Grootveld MC; Sadler PJ, 1985, '1H, 13C NMR, and electronic absorption spectroscopic studies of the interaction of cyanide with aurothiomalate', Journal of Inorganic Biochemistry, vol. 25, pp. 163 - 173, http://dx.doi.org/10.1016/0162-0134(85)80010-6

Günsberg M; Bochner F; Graham G; Imhoff D; Parsons G; Cham B, 1984, 'Disposition of and clinical response to salicylates in patients with rheumatoid disease.', Clin Pharmacol Ther, vol. 35, pp. 585 - 593, http://dx.doi.org/10.1038/clpt.1984.81

Graham GG; Haavisto TM; Jones HM; Champion GD, 1984, 'The effect of cyanide on the uptake of gold by red blood cells', Biochemical Pharmacology, vol. 33, pp. 1257 - 1262, http://dx.doi.org/10.1016/0006-2952(84)90178-3

Graham GG; Haavisto TM; Jones HM; Champion GD, 1984, 'The effect of cyanide on the uptake of gold by red blood cells.', Biochem Pharmacol, vol. 33, pp. 1257 - 1262, http://dx.doi.org/10.1016/0006-2952(84)90178-3

Day RO; Graham GG; Champion GD; Lee E, 1984, 'Anti-rheumatic drug interactions', Clinics in Rheumatic Diseases, vol. 10, pp. 251 - 275

Lee EJD; Williams KM; Graham GG; Day RO; Champion GD, 1984, 'Liquid chromatographic determination and plasma concentration profile of optical isomers of ibuprofen in humans', Journal of Pharmaceutical Sciences, vol. 73, pp. 1542 - 1544, http://dx.doi.org/10.1002/jps.2600731112

Barrett R; Graham GG; Torda TA, 1984, 'The influence of sampling site upon the distribution phase kinetics of thiopentone', Anaesthesia and Intensive Care, vol. 12, pp. 5 - 9

Barratt RL; Graham GG; Torda TA, 1984, 'Kinetics of thiopentone in relation to the site of sampling', British Journal of Anaesthesia, vol. 56, pp. 1385 - 1392, http://dx.doi.org/10.1093/bja/56.12.1385

Graham GG; Day RO; Champion GD; Lee E; Newton K, 1984, 'Aspects of the clinical pharmacology of non-steroidal anti- inflammatory drugs', Clinics in Rheumatic Diseases, vol. 10, pp. 229 - 249

DAY RO; HARRIS G; BROWN M; GRAHAM G, 1983, 'ASPIRIN GLUCOCORTICOSTEROID INTERACTION IN MAN', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, vol. 10, pp. 717 - 717, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RW31100128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

GRAHAM GG; JONES HM; MACPHERSON TM; CHAMPION GD, 1983, 'STUDIES ON THE MECHANISM BY WHICH SMOKING INCREASES THE UPTAKE OF GOLD BY RED-BLOOD-CELLS', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, vol. 10, pp. 674 - 675, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RW31100056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Champion GD; Bieri D; Browne CD; Day RO; Graham GG; Haavisto TM; Sambrook PN; Vallance JB, 1982, 'Auranofin in rheumatoid arthritis.', J Rheumatol Suppl, vol. 8, pp. 137 - 145, https://www.ncbi.nlm.nih.gov/pubmed/6813475

Tung C; Graham GG; Wade DN; Williams KM, 1982, 'The pharmacokinetics of chlorbutol in man', Biopharmaceutics & Drug Disposition, vol. 3, pp. 371 - 378, http://dx.doi.org/10.1002/bdd.2510030410

Graham GG, 1982, 'Noninvasive chemical methods of estimating pharmacokinetic parameters', Pharmacology and Therapeutics, vol. 18, pp. 333 - 349, http://dx.doi.org/10.1016/0163-7258(82)90036-5

IMHOFF D; BOCHNER F; GUNSBERG M; GRAHAM G; PARSONS G; CHAM B; BYRNE G, 1982, 'SALICYLATES IN RHEUMATOID DISEASE', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, vol. 9, pp. 460 - 461, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PJ26400123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Graham GG; Haavisto TM; McNaught PJ; Browne CD; Champion GD, 1982, 'The effect of smoking on the distribution of gold in blood.', J Rheumatol, vol. 9, pp. 527 - 531, https://www.ncbi.nlm.nih.gov/pubmed/6813468

Day RO; Sambrook P; Champion GD; Graham GG, 1982, 'Antimalarials in rheumatic diseases', Australian and New Zealand Journal of Medicine, vol. 12, pp. 645 - 649, http://dx.doi.org/10.1111/j.1445-5994.1982.tb02658.x

HARRIS G; CAIRNS D; BIERI D; CHAMPION D; DAY R; GRAHAM G, 1982, 'RESPONSE OF RHEUMATOID-ARTHRITIS TO SLOWLY ACTING ANTI-RHEUMATIC DRUGS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, vol. 12, pp. 561 - 561, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Liddle C; Graham GG; Christopher RK; Bhuwapathanapun S; Duffield AM, 1981, 'Identification of new urinary metabolites in man of quinine using methane chemical ionization gas chromatography-mass spectrometry', Xenobiotica, vol. 11, pp. 81 - 87, http://dx.doi.org/10.3109/00498258109045277

Graham GG; Champion GD; Haavisto TM; McNaught PJ, 1981, 'Gold binding to red blood cells.', Ann Rheum Dis, vol. 40, pp. 210, http://dx.doi.org/10.1136/ard.40.2.210-a

MCNAUGHT PJ; CHAMPION GD; GRAHAM GG; HAAVISTO TM, 1981, 'THE INFLUENCE OF SMOKING ON THE DISTRIBUTION OF GOLD SODIUM THIOMALATE', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, vol. 11, pp. 723 - 724, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1981MS36500062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

HAAVISTO TM; CHAMPION GD; GRAHAM GG; MCNAUGHT PJ, 1981, 'THE INFLUENCE OF SMOKING ON THE DISTRIBUTION OF GOLD IN BLOOD', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, vol. 8, pp. 674 - 675, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1981NC42000135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Portek I; Graham G; Fleming A, 1981, 'Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability', Medical Journal of Australia, vol. 2, pp. 39 - 40

Bochner F; Graham GG; Cham BE; Imhoff DM; Haavisto TM, 1981, 'Salicylate metabolite kinetics after several salicylates', Clinical Pharmacology and Therapeutics, vol. 30, pp. 266 - 275, http://dx.doi.org/10.1038/clpt.1981.158

Graham GG; Chinwah P; Kennedy M; Wade DN, 1980, 'Monitoring plasma concentrations of drugs', Medical Journal of Australia, vol. 2, pp. 124 - 130

TUNG C; GRAHAM GG; WADE DN; WILLIAMS KM, 1980, 'THE PHARMACOKINETICS OF CHLORBUTOL', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, vol. 7, pp. 672 - 672, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1980KV12600062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

GRAHAM G; CARROLL P; HAAVISTO TM; LAU A; LIDDLE C, 1979, 'COMPARATIVE PHARMACOKINETICS OF QUINE AND QUINIDINE', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, vol. 6, pp. 647 - 647, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1979HV68000022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Borody T; Chinwah PM; Graham GG; Wade DN; Williams KM, 1979, 'Chlorbutol toxicity and dependence.', Med J Aust, vol. 1, pp. 288, https://www.ncbi.nlm.nih.gov/pubmed/449799

Graham GG; Kennedy M, 1979, 'Drug metabolism', Medical Journal of Australia, vol. 1, pp. 441 - 444

Graham GG; Kennedy M, 1979, 'Clinical pharmacokinetics', Medical Journal of Australia, vol. 1, pp. 388 - 385

Graham G; Champion GD; Day RO, 1979, 'The pharmacokinetics of salicyclate in patients with rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, vol. 6, pp. 194

RAY JE; WADE DN; GRAHAM GG; DAY RO, 1979, 'Pharmacokinetics of Carprofen in Plasma and Synovial Fluid', The Journal of Clinical Pharmacology, vol. 19, pp. 635 - 643, http://dx.doi.org/10.1002/j.1552-4604.1979.tb01626.x

LIDDLE C; BHUWAPATHANAPUN S; CHRISTOPHER RK; GRAHAM GG; DUFFIELD AM, 1979, 'IDENTIFICATION BY GC/MS OF SOME QUININE METABOLITES IN URINE', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, vol. 6, pp. 171 - 171, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1979GL67900013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Graham GG; Kennedy M, 1978, 'Drug absorption and bioavailability', Medical Journal of Australia, vol. 2, pp. 143 - 147

Champion GD; Day RO; Paull PD; Graham GG; Owen MS; Haski AL; Hills L, 1978, 'Clinical Pharmacology and Efficacy of Benorylate in Patients with Rheumatoid Arthritis', Australian and New Zealand Journal of Medicine, vol. 8, pp. 22 - 28, http://dx.doi.org/10.1111/j.1445-5994.1978.tb02398.x

Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG, 1977, 'The Effects of Enteric Coating of Aspirin Tablets on Occult Gastrointestinal Blood Loss', Australian and New Zealand Journal of Medicine, vol. 7, pp. 600 - 604, http://dx.doi.org/10.1111/j.1445-5994.1977.tb02315.x

Graham GG; Champion GD; Day RO; Kaski AL; Hills LG; Paull PD, 1977, 'Salicylates in rheumatoid arthritis: pharmacokinetics and analgesic response.', Agents and Actions Supplements, pp. 37 - 42

Graham GG; Champion GD; Day RO; Paull PD, 1977, 'Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, vol. 22, pp. 410 - 420, http://dx.doi.org/10.1002/cpt1977224410

Birkett DJ; Graham GG; Chinwah PM; Wade DN; Hickie JB, 1977, 'Multiple drug interactions with phenytoin.', Med J Aust, vol. 2, pp. 467 - 468, https://www.ncbi.nlm.nih.gov/pubmed/600148

Graham G; Champion GD; Day RO; Paull PD, 1977, 'The pharmacokinetics of salicylate in patients with rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, vol. 4, pp. 214

Champion GD; Day RO; Fagan N, 1977, 'Single dose comparison of analgesic action of acetylsalicylate and sodium salicylate in rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, vol. 4, pp. 213

Day RO; Paull PD; Champion GD; Graham GG, 1976, 'Evaluation of an Enteric Coated Aspirin Preparation', Australian and New Zealand Journal of Medicine, vol. 6, pp. 45 - 50, http://dx.doi.org/10.1111/j.1445-5994.1976.tb03290.x

Paull P; Day R; Graham G; Champion D, 1976, 'Single dose evaluation of a new enteric coated aspirin preparation', Medical Journal of Australia, vol. 1, pp. 617 - 619

Graham GG; Champion GD, 1976, 'Correlation of plateau serum salicylate with rate of salicylate metabolism', Clinical Pharmacology and Therapeutics, vol. 20, pp. 120 - 122

Paull PD; Day RO; Graham GG; Champion GD, 1975, 'Bioavailability of enteric coated aspirin', Clinical and Experimental Pharmacology and Physiology, vol. 2, pp. 442

Bolt AG; Graham G; Wilson P, 1974, 'Stereoselective demethylation of the enantiomers of nefopam, an experimental antidepressant and skeletal muscle relaxant', Xenobiotica, vol. 4, pp. 355 - 363, http://dx.doi.org/10.3109/00498257409052111

Graham G; Bolt AG, 1974, 'Half-life of diphenylpyraline in man', Journal of Pharmacokinetics and Biopharmaceutics, vol. 2, pp. 191 - 195, http://dx.doi.org/10.1007/BF01059761

Rowland M; Benet LZ; Graham GG, 1973, 'Clearance concepts in pharmacokinetics', Journal of Pharmacokinetics and Biopharmaceutics, vol. 1, pp. 123 - 136, http://dx.doi.org/10.1007/BF01059626

Graham G; Rowland M, 1972, 'Application of salivary salicylate data to biopharmaceutical studies of salicylates', Journal of Pharmaceutical Sciences, vol. 61, pp. 1219 - 1222, http://dx.doi.org/10.1002/jps.2600610810

Graham G; Sleigh MJ; Bolt AG, 1972, 'Measurements of monoamine oxidase activity using [¹⁴C]tryptamine', Journal of Pharmacy and Pharmacology, vol. 24, pp. 909 - 911, http://dx.doi.org/10.1111/j.2042-7158.1972.tb08914.x

Conference Papers

Zin T; Graham GG; Mclachlan AJ; Tett S, 1998, 'Differences in the pharmacokinetics of mefloquine enantiomers between Australian and Burmese subjects', in Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, ASCEPT: 32nd Annual Scientific Meeting, Hobart, pp. 147, presented at ASCEPT: 32nd Annual Scientific Meeting, Hobart, 01 December 1998

Graham GG; Mortlet N; Gatus BJ; Maclean AL; Salonikas C; Naidoo D; Goldberg I, 1997, 'The pharmacokinetics of ciproflacin in the human eye: a population pharmacokinetic analysis', in Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Australian Society of Clinical and Experimental Pharmacology and Toxicology, Canberra, presented at Australian Society of Clinical and Experimental Pharmacology and Toxicology, Canberra, 30 November - 01 December 1997

Daly EB; Graham GG; Torda TA, 1997, 'Pharmacokinetic analysis of time course of atracurium', in Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Australian Society of Clinical and Experimental Pharmacology and Toxicology, Canberra, presented at Australian Society of Clinical and Experimental Pharmacology and Toxicology, Canberra, 30 November - 01 December 1997

Quane PA; Graham GG; Zeigler J, 1997, 'Effects of benzydamine on the oxidative burst of neutrophils and on lactoperoxidase', in Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Australian Society of Clinical and Experimental Pharmacology and Toxicology, Canberra, presented at Australian Society of Clinical and Experimental Pharmacology and Toxicology, Canberra, 30 November - 01 December 1997

Bolisetty S; Gupta J; Graham GG; Salonikas C; Naidoo D, 1997, 'Regular vitamin K supplementation to lactating mothers - does it help?', in Annual Congress of the Australian and New Zealand Perinatal Society, Annual Congress of the Australian and New Zealand Perinatal Society, presented at Annual Congress of the Australian and New Zealand Perinatal Society, 01 January 1997

Graham GG; Ziegler JB; Champion GD, 1993, 'Medicinal chemistry of gold', in Agents and Actions, pp. 209 - 217

RUDKOWSKI R; CHAMPION GD; GRAHAM GG; ZIEGLER JB, 1986, 'THE EFFECTS OF AUROCYANIDE, AUROTHIOMALATE AND AURANOFIN ON THE OXIDATIVE BURST OF POLYMORPHONUCLEAR LEUKOCYTES', in AUSTRALIAN PAEDIATRIC JOURNAL, BLACKWELL SCIENCE, pp. 337 - 338, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986H083600045&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Reports

Kumar SS; Graham GG; Smith FC; Furlong TJ; Greenfield JR; Stocker SS; Carland JE; Day RO, 2017, Could metformin be used in patients with advanced chronic kidney disease?, http://dx.doi.org/10.1111/dom.12806

Conference Presentations

Conference Abstracts

Kannangara D; Graham G; Wright D; Barclay M; Stamp L; Williams K; Day R, 2015, 'TREATING GOUT PATIENTS WITH ALLOPURINOL: A CONCENTRATION- OR DOSE-RESPONSE APPROACH?', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 45, pp. 13 - 13, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Tabs